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they can appear in the lung, heart, larynx and Achilles tendon
[2]. Methotrexate nodulosis is rare in patients with rheuma-
toid arthritis who are negative for rheumatoid factor [3].
Nodules often, but not always, regress or disappear on
discontinuing the drug [3].
Methotrexate nodulosis in conditions other than rheumatoid
arthritis is very rare. It has been reported in a patient with
systemic lupus erythematosus and Jaccoud’s arthropathy [4], a
patient with juvenile arthritis who was rheumatoid factor
negative [5], and a patient with psoriatic arthritis and negative
rheumatoid factor [6]. Only the patient with juvenile arthritis
had pulmonary nodules. However, a recent case report
describes a patient similar to ours with psoriatic arthritis and
negative rheumatoid factor who developed accelerated pul-
monary nodulosis and a sterile pleural effusion after treatment
with methotrexate [7]. Open lung biopsy showed histology
compatible with a rheumatoid nodule. The nodules resolved
on stopping methotrexate treatment.
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Talcosis due to abundant use of cosmetic talcum
powder
To the Editor:
A 36-yr-old, nonsmoking, Hindustan female presented with
complaints of dyspnoea without coughing which had persisted
for several months. The complaints started after a bout of
pneumonia a few months previously. Her medical history was
unremarkable. She did not suffer from asthma, nor did asthma
run in the family. She worked at an administrative office.
Physical examination showed no abnormalities; in particular,
the auscultation of the lungs was normal. A screening
laboratory examination, including complete blood count, renal
function and liver function tests, was normal. A chest radio-
graph showed nodular lesions in both lungs (fig. 1a).
Because of the abnormal chest radiograph, a second patient
history was carried out and revealed a remarkable twice daily
bathing ritual where she used large amounts of cosmetic
talcum powder. After bathing the patient powdered her whole
body with talcum powder, a ritual she had carried out since
her childhood. Ancillary laboratory investigations including
angiotensin converting enzyme, total immunoglobulin E
and anti-cyclic citrullinated peptide were all negative. A
high-resolution computed tomography (CT) scan of the thorax
showed a diffuse nodular image in both lungs. Interlobular
septa and pleura showed a normal pattern (fig. 1b). Pulmonary
function tests showed a restrictive pattern, with a normal
diffusion capacity. Bronchoscopy did not reveal any endo-
bronchial abnormalities. Bronchoalveolar lavage was negative
for mycobacteria and other infectious agents, and no neoplastic
cells were found. Inflammatory cell distribution was normal,
including a CD4/CD8 ratio of 0.9 (normal,2.5). Transbronchial
lung biopsies showed patchy peribronchiolar fibrosis and an
extensive non-caseating granulomatous inflammation with
numerous multinucleair giant cells associated with the massive
presence of needle-shaped birefringent crystalline material
(fig. 2a and b). Pulmonary vessels showed no abnormalities.
No asbestos bodies were observed.
For tissue analysis by energy-dispersive X-ray spectroscopy
(EDX), haematoxylin and eosin stained sections of paraffin
embedded lung specimens were screened for birefringent
crystals. Small areas were chosen from the paraffin blocks,
dissected, de-paraffinised and then embedded in Epon
according to Luft’s procedure (Merck, Darmstadt, Germany).
Ultra-thin sections (200 nm) were cut on an ultra-microtome
(Leica Microsystems, Wetzlar, Germany) and examined in a c
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1200 EXII electronmicroscope (Jeol, Tokyo, Japan). For genera-
tion of the EDX spectra, the scanning transmission electron
microscope mode was used. Spectra of the chosen areas were
generated with the point and shoot utility using the tracor
northern system 6 detector (Thermo Noran, Middleton, WI,
USA). Ultra structural examination of these birefringent
crystals was performed in the electronmicroscope (1200EX II;
Jeol) for morphology, localisation and diffraction pattern.
Extracellular sheets and fibres were found in extensive
amounts (fig. 2c). EDX analysis of the crystals in the lung
biopsy specimen showed particles of magnesium, silicon and
sporadical chlorine. The structure of these particles, together
with the presence of magnesium and silicon, was consistent
with talc (fig. 2d).
Based on the patient’s history and the clinical, radiological,
histological and mineralogical findings, and by the exclusion of
other plausible causes, the diagnosis of talc induced interstitial
lung disease (talcosis) was made based on abundant use of
cosmetic talcum powder. At 1-yr follow-up the patient had
discontinued her bathing ritual; the complaints had decreased
and pulmonary function had increased. The chest radiograph
did not show an improvement and the nodular lesions in both
lungs remained unchanged.
Pulmonary disease due to talc is almost exclusively encoun-
tered secondary to occupational exposure or intravenous drug
abuse. Talcosis or talc pneumoconiosis is one of the rarer forms
of silicate induced lung disease. It has been described in
workers exposed to talc during its production or its industrial
use. Very often, the history of exposure is not recognised by the
patient. However, talcosis can also be caused due to the use of
cosmetic talcum powder. High-purity talc is used in cosmetic
and pharmaceutical industries and there is no conclusive
evidence that cosmetic talc, when used as intended, presents a
health hazard [1].
In 1979 WELLS et al. [2] described a case which shows
remarkable parallels with this case report. The patient was in
the habit of dusting the whole body with talc at least once daily
and the talc had been applied in a small unventilated room
likely to favour inhalation [2]. However, it was THOREL [3] who
reported the first case of talc pneumoconiosis in 1896.
Following this there have been several written reports of
talcosis due to cosmetic talcum powder; however, the course
can be quite different [4–9]. Despite these reports the
prevalence of talcosis due to the abundant use of cosmetic
talcum powder is not as high as could be expected according to
the common use of cosmetic talcum powder.
Radiographic findings may include generalised haziness,
nodulation and reticulation similar to those observed in
asbestosis, but the apices and costophrenic sulci are generally
spared in talcosis. As in other forms of pneumoconiosis,
nodule confluence results in large opacities that resemble those
in progressive massive fibrosis. In some patients, hilar
lymphadenopathy develops. High-resolution CT scan findings
in patients with talcosis caused by inhaled particulates include
small centrilobular and subpleural nodules and heterogeneous
conglomerate masses with internal foci of high attenuation that
are consistent with talc deposition [10]. In our patient, the size
and location of the nodules supports the diagnosis of talcosis.
Apart from a patient history, a biopsy is necessary to make the
diagnosis. The pathological features of talc inhalation have
been described as either fibrosis reaction, which can be diffuse
interstitial or irregular nodular, or as non-caseating granulo-
matous reaction. Microscopic examination under polarised
light reveals birefringent needle-shaped particles in multi-
nucleated giant cells and macrophages. These pathological
features differ from pulmonary findings seen after intravenous
talc injection. In pulmonary findings seen after intravenous talc
injection the particles are larger and characteristic intravascular
and perivascular granulomas can be seen [4]. In our patient, the
size of the particles, the location of the granulomas and the lack
of intravascular and perivascular lesions support inhalation as
mode of entry of the talc into the lungs.
This case emphasises the importance of a thorough medical
history. On basis of the patient’s history and the compatible
a)
b)
FIGURE 1. Radiodiagnostic imaging. a) A chest radiograph showing multiple
nodular lesions in both lungs. b) A high-resolution computed tomography scan showing
a diffuse nodular image in both lungs. Interlobular septa and pleura were normal.
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clinical, radiological, histological and mineralogical findings,
as well as the exclusion of other plausible causes, a diagnosis of
talcosis due to abundant cosmetic talcum powder was made.
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FIGURE 2. Transbronchial lung biopsy microscopic slide of a) lung tissue showing a granulomatous inflammation with giant cell reaction and b) lung tissue under
polarised light (birefringed crystalline material). c) Scanning transmission electron micrograph of the lung biopsy specimen showing sheets and fibres. In this area five
different points were selected with the point and shoot utility. Points 1–4: electron dense crystalline material; point 5: control area. Scale bar5100 nm. d) Energy-dispersive
spectroscopy spectrum of point 1, all crystals in the lung biopsy specimen showed peaks for magnesium (Mg) and silicon (Si) in a ratio consistent with talc. Reference
measurements such as point 5, however, only showed peaks for copper (Cu), originating from the copper carrier grid.
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